Demographic and health care service utilization by 4417 patients with hidradenitis suppurativa
| Autor: | Jacob Dreiher, Shmuel Tiosano, Doron Comaneshter, Arnon D. Cohen, Meir Babaev, Nadav Pam, Daniel A. Vardy, Amir Horev, Tamar Freud, Guy Shalom |
|---|---|
| Rok vydání: | 2017 |
| Předmět: |
Adult
Male medicine.medical_specialty Multivariate analysis Population Dermatology 030207 dermatology & venereal diseases 03 medical and health sciences 0302 clinical medicine Internal medicine Health care Epidemiology medicine Humans Hidradenitis suppurativa education education.field_of_study business.industry Odds ratio Patient Acceptance of Health Care medicine.disease Confidence interval Hidradenitis Suppurativa Cross-Sectional Studies 030220 oncology & carcinogenesis Physical therapy Female business Body mass index |
| Zdroj: | Journal of the American Academy of Dermatology. 77(6) |
| ISSN: | 1097-6787 |
| Popis: | Background Data on the health care utilization of patients with hidradenitis suppurativa (HS) in primary care settings are scarce. Objective To investigate the health care service utilization of patients with HS. Methods In a cross-sectional study, patients with HS were compared with 2 age- and sex-matched control groups—general population enrollees of Clalit Health Services and a group of patients with psoriasis. Health care services data included inpatient and outpatient community clinic visits and pharmacy claims for topical and systemic treatments. Multivariate analysis of the data for patients with HS and controls was performed. Results The study included 4417 patients with HS, 22,085 general population enrollees, and 4417 patients with psoriasis. On the basis of multivariate analyses, patients with HS had more annual dermatology clinic visits compared with the general population enrollees (odds ratio [OR], 6.49; 95% confidence interval [CI], 7.06-5.97) and patients with psoriasis (OR, 1.32; 95% CI, 1.44-1.21), more annual surgical clinic visits (OR, 3.78; 95% CI 3.28-4.36 and OR, 1.65; 95% CI, 1.42-1.91, respectively), and more hospitalizations (OR, 2.21; 95% CI, 1.89-2.56 and OR, 1.51; 95% CI, 1.28-1.78, respectively). Limitations Underestimation of HS frequency was possible. Conclusions The burden on health care systems due to patients with HS is greater than that due to patients with psoriasis and the general population. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect